Skip to content

๐…๐จ๐ซ๐’๐ข๐ ๐ก๐ญ ๐‘๐จ๐›๐จ๐ญ๐ข๐œ๐ฌ ๐’๐ž๐œ๐ฎ๐ซ๐ž $125๐ฆ ๐ข๐ง ๐…๐ฎ๐ง๐๐ข๐ง๐  ๐Ÿ๐จ๐ซ ๐ง๐ž๐ฐ ๐’๐ฎ๐ซ๐ ๐ข๐œ๐š๐ฅ ๐๐ฅ๐š๐ญ๐Ÿ๐จ๐ซ๐ฆ

 ForSight Robotics has raised $125 million to advance its revolutionary surgical platform, ORYOM, into the next stage of development.
Named after the Hebrew word for โ€œdaylight,โ€ ORYOM is the worldโ€™s first robotic system built to autonomously perform intraocular surgeries, powered by AI-driven computer vision for unparalleled precision. With over 600 million people globally affected by cataracts, this innovation could be a game-changer in the battle against preventable blindness, helping to bridge the growing gap in access to advanced ophthalmic care. Human clinical trials are on the horizon, and if successful, ORYOM could redefine global standards for vision-restoring procedures.